ALB and Hyperbilirubinemia: Factors which increase UCBFREE, such as hypoalbuminemia, hyperbilirubinemia, and the presence of drugs which displace bilirubin from its binding sites on albumin, as well as BBB damage, have a clinical relevance in bilirubin-induced neurotoxicity.